Myomo Inc

CEO Paul Gudonis buys 19,395 Myomo shares, boosting ownership to 48% and signaling confidence in the company’s robotic‑healthcare future.

CEO Paul Gudonis’s new RSU purchase fuels optimism for Myomo’s growth, showing insider confidence in exoskeleton innovation and potential upside for investors.

CEO Paul Gudonis’s 19,395‑RSU salary‑swap deal at Myomo signals insider confidence, aligns interests, and may calm volatility while boosting long‑term investor sentiment.

Insider buying surge at Myomo: Getz Heather C. adds 20k shares at $0.70, signaling confidence in medical robotics growth and a potential turnaround from its steep decline.

Insider buying in Myomo Inc. signals management confidence amid a steep 87% decline, suggesting potential upside for investors if earnings improve.